Effects of α1-acid glycoprotein on hemostasis in experimental septic peritonitis
Authors:
- 1 August 2007
- journal article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 144 (2) , 178-180
Abstract
Pathogenesis of hemostasis disorders in septic peritonitis and the possibility of their correction with acute phase protein (α1-acid glycoprotein; two doses of 150 mg/kg) were experimentally studied on outbred albino rats. Platelets count in the peripheral blood and their adhesion to endothelium did not change during peritonitis, while aggregation activity increased due to increased rate and shorter time of aggregation, which was associated with the development of hypercoagulation involving the intrinsic and common coagulation pathways and reduction of antithrombin activity. α1-Acid glycoprotein increased platelet count above the normal level, normalized aggregation rate, some blood clotting parameters, and antithrombin activity. Hence, α1-acid glycoprotein is a polyfunctional protein modulating all pathogenetic components in the development of blood clotting disorders during septic peritonitis.Keywords
This publication has 3 references indexed in Scilit:
- Role of coagulation FVIII in septic peritonitis assessed in hemophilic miceJournal of Thrombosis and Haemostasis, 2005
- Acute Phase Protein α1-Acid Glycoprotein Interacts with Plasminogen Activator Inhibitor Type 1 and Stabilizes Its Inhibitory ActivityJournal of Biological Chemistry, 2001
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999